IO Drugs: Key to the Cancer Moonshot?



7:00am - 8:00am

Live Webinar

Checkpoint inhibitor immuno-oncology (IO) treatments, widely considered as one the most promising breakthroughs in drug development, are a focus of the Cancer Moonshot initiative. But are these new therapies getting reimbursed and what are the challenges they face in gaining market access?

Join us for a live webinar to take a data-driven look at the key challenges facing IO drugs including:
– Cost and value
– Interpretation of clinical efficacy evidence
– Restrictions issued by HTA agencies

Click Here for More Information

Contact: Lorraine Versoza
Contact Phone: 323-640-5096
Contact Email: